Showing results (281-290 of 398) with videos related to

Sort By:
Pageof 40
Investigational New Drugs|September 10, 2013
Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patientsSu Jin Lee, Jongtae Lee, Jeeyun Lee, et al.
Annals of Surgical Oncology|December 6, 2013
CD151 overexpression is associated with poor prognosis in patients with pT3 gastric cancerSang Yun Ha, In-Gu Do, Jeeyun Lee, et al.
Journal of Cancer|July 11, 2019
High delta-like ligand 4 expression correlates with a poor clinical outcome in gastric cancerYoujin Kim, Sun-Ju Byeon, Joonyoung Hur, et al.
Clinical Colorectal Cancer|March 20, 2018
Phase I Trial of Anti-MET Monoclonal Antibody in MET-Overexpressed Refractory CancerJeeyun Lee, Seung Tae Kim, Sungju Park, et al.
The American Journal of Surgical Pathology|January 27, 2007
Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patientsDae Young Kang, Cheol Keun Park, Jong Sang Choi, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 31, 2016
Detecting Gene Rearrangements in Patient Populations Through a 2-Step Diagnostic Test Comprised of Rapid IHC Enrichment Followed by Sensitive Next-Generation SequencingDanielle A Murphy, Heather A Ely, Robert Shoemaker, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 28, 2016
FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survivalSoomin Ahn, Jeeyun Lee, Mineui Hong, et al.
Pageof 40